Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism.
about
Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-kappaB8-(Tosylamino)quinoline inhibits macrophage-mediated inflammation by suppressing NF-κB signaling.Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages.Lysophosphatidic acid in atherosclerotic diseasesSphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism.Mechanism of sphingosine 1-phosphate- and lysophosphatidic acid-induced up-regulation of adhesion molecules and eosinophil chemoattractant in nerve cells.Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.Bcl10 and Malt1 control lysophosphatidic acid-induced NF-kappaB activation and cytokine production.BAY 11-7082 is a broad-spectrum inhibitor with anti-inflammatory activity against multiple targets.Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration.Stabilizing endothelium of donor hearts with fusogenic liposomes reduces myocardial injury and dysfunctionRho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.Lysophosphatidic acid can support the formation of membranous structures and an increase in MBP mRNA levels in differentiating oligodendrocytesRole of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.Inflammatory and microenvironmental factors involved in breast cancer progression.Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.Filamin A Expression Negatively Regulates Sphingosine-1-Phosphate-Induced NF-κB Activation in Melanoma Cells by Inhibition of Akt SignalingDual Role of the Extracellular Domain of Human Mucin MUC1 in Metastasis.Lysophosphatidic acid effects on atherosclerosis and thrombosis.S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.Lipidomic analysis of human plasma reveals ether-linked lipids that are elevated in morbidly obese humans compared to lean.Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65.Inhibiting NF-κB in the developing lung disrupts angiogenesis and alveolarization.ROCK as a Therapeutic Target of Diabetic RetinopathyComparison of the effect of intravitreal bevacizumab and intravitreal fasudil on retinal VEGF, TNFα, and caspase 3 levels in an experimental diabetes model.Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient miceNitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells independent of cGMP- or NFκB-mediated mechanisms.Expression of autotaxin and acylglycerol kinase in proliferative vitreoretinal epiretinal membranes.Sphingosine-1-Phosphate-Specific G Protein-Coupled Receptors as Novel Therapeutic Targets for Atherosclerosis.
P2860
Q24300560-A9687CD0-99EB-40EE-8AC1-C7B8BBBC932AQ33571283-5C355362-4C35-4250-A550-8A463845261CQ33607215-EDFD235E-CAF8-43BF-B9EA-8D8DB5A12612Q34273486-D983FE27-30A0-440B-8A15-34C0F4894AFFQ34571684-57636557-7C6E-4C78-936D-C590C51136C0Q35048605-B4FA61FA-196D-4CC3-8654-4F270BCE02F3Q35130512-08664C13-754F-4C0B-93AD-21EFF077E700Q35575886-CB32E2D6-9CF4-43C5-B40F-A1562F886CD6Q36055896-583B61BB-7BE1-4B4D-B10E-BECA3F133C6BQ36470222-E5CB9437-B2E0-4F1C-9255-B60525B56A04Q36746563-DD11546E-ED6A-402A-9E53-8CA345B529DCQ37023057-29C5936D-9D1C-4C9E-A190-E4AE535F0190Q37119859-97CE75E1-2C3A-46BD-866A-60123E4C50A0Q37871354-176F632A-C4A4-49E3-A3FF-92C7660145CDQ38162168-1903E6DC-A317-432A-ABBE-39F61392BAA5Q38307971-2BAEBE95-EC3F-4661-9A7A-ED623086D490Q38820716-310AA4D9-A1D8-4D88-B569-E6C872F48044Q38838151-444FCF3C-31E0-4495-8AA3-106C69938527Q39608397-9358F362-1E57-4677-B162-BE30DF8F06CFQ39846364-598B4890-FAF0-47F3-844C-85E88980981AQ41026278-6E33B850-80A8-479B-B69C-34A19DBB4B4FQ41331100-4C5EF45F-EE24-409F-BE10-5B207B698119Q41824496-2F04943B-EBF2-4D57-B783-B918979DFEAEQ41873958-F31A70B5-5BF3-43DE-8842-D484860CAF85Q42260229-F4628BFF-C8B8-4F9A-BF64-20ECD6F671ADQ42363985-9132F8A6-93AD-4244-B7B7-ECFD656D8070Q51827526-7B763A5A-8435-43FA-8D55-7E8B0E390EBFQ54548435-689ED046-16DC-4FBD-8ACD-482D2924D35EQ55564395-28F87ECA-E4C3-456F-808B-DE27F2E05D84
P2860
Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-kappaB-dependent mechanism.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lysophospholipids increase ICA ...... NF-kappaB-dependent mechanism.
@en
type
label
Lysophospholipids increase ICA ...... NF-kappaB-dependent mechanism.
@en
prefLabel
Lysophospholipids increase ICA ...... NF-kappaB-dependent mechanism.
@en
P2093
P2860
P1476
Lysophospholipids increase ICA ...... NF-kappaB-dependent mechanism.
@en
P2093
Chi Iou Lin
Chung-Ying Lee
Hsi Yuan Yang
Hsien-Yeh Hsu
Hsinyu Lee
Hua Lin Wu
Jia-Jun Liao
Yu-Wei Lee
P2860
P304
P356
10.1152/AJPCELL.00172.2004
P577
2004-08-04T00:00:00Z